Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 15.69 | 14.82 | 14.82 | 14.17 | 14.17 |
| Share application money | 1.39 | 0.94 | 0.94 | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 78.95 | 71.56 | 63.56 | 51.77 | 62.69 |
| Loan funds | |||||
| Secured loans | 125.23 | 98.01 | 98.98 | 93.75 | 96.81 |
| Unsecured loans | - | - | - | - | - |
| Total | 221.26 | 185.33 | 178.30 | 159.70 | 173.67 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 95.80 | 82.79 | 78.29 | 75.69 | 70.85 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 32.73 | 29.89 | 25.64 | 19.56 | 13.91 |
| Net block | 63.07 | 52.90 | 52.65 | 56.14 | 56.94 |
| Capital work-in-progress | - | 1.16 | - | 0.11 | 0.06 |
| Investments | 8.40 | 8.40 | 8.40 | 7.42 | 7.44 |
| Net current assets | |||||
| Current assets, loans & advances | 276.24 | 227.16 | 200.49 | 175.66 | 192.71 |
| Less : current liabilities & provisions | 126.44 | 104.29 | 83.24 | 79.62 | 83.48 |
| Total net current assets | 149.80 | 122.87 | 117.25 | 96.04 | 109.23 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 221.26 | 185.33 | 178.30 | 159.70 | 173.67 |
| Notes: | |||||
| Book value of unquoted investments | - | - | 9.57 | 8.59 | 7.44 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 16.44 | 16.25 | 4.34 | 12.99 | 20.37 |
| Number of equity sharesoutstanding (Lacs) | 156.90 | 148.22 | 148.22 | 141.72 | 141.72 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis